Robert Jenkins, M.D., Ph.D. (PATH ’87), Division of Laboratory Genetics and Genomics, Mayo Clinic Rochester
Robert Jenkins, M.D., Ph.D. (PATH ’87), Division of Laboratory Genetics and Genomics at Mayo Clinic in Rochester and a Ting Tsung and Wei Fong Chao Professor in Individualized Medicine Research, co-authored a study that identified the biologic mechanism of a germline alteration that may be critical for developing new therapies to treat and prevent a type of brain tumor. The findings are published in the Oct. 7, 2022, issue of the journal Science, and the results have relevance to other cancers and diseases. The research was led by the Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital, Toronto; Mayo Clinic Comprehensive Cancer Center; and Mayo Clinic Center for Individualized Medicine. Dr. Jenkins is a professor of laboratory medicine and pathology in the Mayo Clinic College of Medicine and Science.